Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,704 papers from all fields of science
Search
Sign In
Create Free Account
ecadotril
Known as:
acetorphan, (S)-isomer
, sinorphan
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
racecadotril
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
R. Baliga
,
C. Scotton
,
S. Trinder
,
R. Chambers
,
R. Macallister
,
A. Hobbs
British Journal of Pharmacology
2014
Corpus ID: 17768309
Idiopathic pulmonary fibrosis (IPF) is a progressive fibro‐proliferative disorder refractory to current therapy commonly…
Expand
2004
2004
The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat
A. Sulpizio
,
M. Pullen
,
R. Edwards
,
D. Brooks
Journal of Pharmacology and Experimental…
2004
Corpus ID: 950851
The effect of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) inhibition on microvascular plasma leakage…
Expand
2000
2000
Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine‐induced hypertension
Y. Takeda
,
S. Inaba
,
K. Furukawa
,
A. Fujimura
,
I. Miyamori
,
H. Mabuchi
Journal of Hypertension
2000
Corpus ID: 36174248
Objective Cyclosporine (CysA), a potent immunosuppressant, is associated with hypertension and nephrotoxicity. Neutral…
Expand
1999
1999
Novel Neurohormonal Modulators in Cardiovascular Disorders
M. Kentsch
,
W. Otter
1999
Corpus ID: 58506264
Since angiotensin II is an established target of pharmacological interventions, there is an increasing interest in the biological…
Expand
Review
1999
Review
1999
Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitors.
M. Kentsch
,
W. Otter
Drugs in R&D
1999
Corpus ID: 523255
Since angiotensin II is an established target of pharmacological interventions, there is an increasing interest in the biological…
Expand
1995
1995
Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
J. Stasch
,
A. Knorr
,
M. Wegner
,
C. Hirth‐Dietrich
Hypertension Research
1995
Corpus ID: 36180649
The cardiovascular consequences of inhibition of the neutral endopeptidase 24.11 (NEP) with the orally active NEP inhibitor…
Expand
1995
1995
Sinorphan Improves Cardiac Structure and Function in Aged Stroke-Prone Spontaneously Hypertensive Rats
A. Knorr
,
C. Hirth‐Dietrich
,
J. Stasch
,
S. Kazda
1995
Corpus ID: 73159179
Inhibition of atrial natriuretic peptide (ANP) degradation by enkephalinase is known to increase endogenous ANP levels and to…
Expand
1993
1993
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
J. Dussaule
,
C. Michel
,
+4 authors
Raymond Ardaillou
Clinical science
1993
Corpus ID: 43109881
1. The acute effects of a single oral dose of sinorphan (100 mg), an inhibitor of neutral endopeptidase, on the plasma atrial…
Expand
Review
1991
Review
1991
[New approach in the research of analgesics and antihypertensive agents].
B. Roques
Annales Pharmaceutiques Françaises
1991
Corpus ID: 34065334
The activation or interruption of the responses induced by regulatory peptides are ensured by ectoenzymes, the most important of…
Expand
1990
1990
Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: Role of enkephalinase (EC 3.4.24.11)
C. Gros
,
A. Souque
,
J. Schwartz
Neuropeptides
1990
Corpus ID: 22180352
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE